Emergency Management: Patient Without a Pulse
If a patient has no pulse, this is cardiac arrest—immediately initiate cardiopulmonary resuscitation (CPR) and activate emergency response systems; lip bleeding is irrelevant until return of spontaneous circulation (ROSC) is achieved. 1
Immediate Life-Saving Actions
Primary Survey - ABCs Take Absolute Priority
- Check for pulse at carotid or femoral artery for no more than 10 seconds - absence of pulse = cardiac arrest requiring immediate CPR 1
- Begin high-quality chest compressions immediately at a rate of 100-120/minute with depth of at least 2 inches in adults 1
- Call for help and activate emergency medical services - ensure defibrillator/AED is brought to bedside 1
- Establish airway and provide rescue breathing at 30:2 compression-to-ventilation ratio if no advanced airway 1
Anticoagulation Considerations During Cardiac Arrest
- Do NOT withhold or delay CPR due to anticoagulation status - survival takes absolute precedence over bleeding risk 1
- Continue standard ACLS protocols without modification for anticoagulated patients 1
- Aggressive volume resuscitation with isotonic crystalloids (0.9% NaCl or Ringer's lactate) should be initiated once IV access is obtained 1
Post-ROSC Management of Lip Bleeding
Only After Pulse is Restored
If the patient achieves ROSC and has ongoing lip bleeding, classify the bleeding severity using ACC criteria: 1
Non-Major Lip Bleeding (Most Likely Scenario)
- Apply direct manual compression with gauze soaked in tranexamic acid for 3-5 minutes 2
- Stop oral anticoagulants temporarily but do NOT administer reversal agents for non-major bleeding 1
- If on warfarin, consider 2-5 mg PO/IV vitamin K (not mandatory for non-major bleeds) 1
- Assess for contributing factors: thrombocytopenia, uremia, liver disease, antiplatelet agents 1
Major Lip Bleeding (Rare - requires hemodynamic instability OR Hgb drop ≥2 g/dL OR ≥2 units RBC transfusion)
- Stop all anticoagulants and antiplatelet agents immediately 1, 2
- Apply local hemostatic measures with tranexamic acid-soaked gauze 2
- If on warfarin: give 5-10 mg IV vitamin K 1
- If on DOACs: administer specific reversal agents (idarucizumab for dabigatran; andexanet alfa for apixaban/rivaroxaban) 1
- Consider ENT/oral surgery consultation for cauterization or suturing if local measures fail 2
Critical Pitfalls to Avoid
- Never delay cardiac arrest management for bleeding concerns - mortality from cardiac arrest far exceeds bleeding risk 1
- Do NOT give PCC, vitamin K, idarucizumab, or andexanet alfa for antiplatelet therapy - these are exclusively for anticoagulant reversal 2, 3
- Do NOT routinely transfuse platelets for antiplatelet-associated bleeding - evidence shows potential harm in intracranial hemorrhage 1
Transfusion Thresholds Post-ROSC
- Maintain hemoglobin ≥7 g/dL for symptomatic anemia or active bleeding 1
- Target hemoglobin ≥8 g/dL if underlying coronary artery disease or acute coronary syndrome 1
- Target platelet count >50,000/μL if transfusing for active oral bleeding 2